Ian E. Anglin
Impact in
- Urology top 10%
- Urinary Bladder and Prostate Research
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 2
- Angiogenesis and VEGF in Cancer 1
- Oncology 3
- Co-authors
- Natasha Kyprianou (2 shared papers)James Partin (1 shared paper)Antonino Passaniti (4 shared papers)Deborah T. Glassman (1 shared paper)Michele Vítolo (3 shared papers)Toni Antalis (2 shared papers)Kurtis E. Bachman (1 shared paper)Ronald B. Gartenhaus (1 shared paper)
- Journals
- International Journal of Cancer (1 paper)Experimental Lung Research (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)Cancer Biology & Therapy (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- United StatesThailandAustralia
In The Last Decade
Ian E. Anglin
11 papers receiving 453 citations
Peers
Comparison fields: 5 of 70
- Urology 35
- Cancer Research 76
- Cell Biology 87
- Molecular Biology 222
- Oncology 79
Countries citing papers authored by Ian E. Anglin
This map shows the geographic impact of Ian E. Anglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. Anglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. Anglin more than expected).
Fields of papers citing papers by Ian E. Anglin
This network shows the impact of papers produced by Ian E. Anglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. Anglin. The network helps show where Ian E. Anglin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian E. Anglin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 92 | |
| 2 | 2002 | 65 | |
| 3 | 2007 | 63 | |
| 4 | 2008 | 54 | |
| 5 | 2001 | 50 | |
| 6 | 2004 | 41 | |
| 7 | 2013 | 32 | |
| 8 | 2011 | 26 | |
| 9 | 2006 | 19 | |
| 10 | 2011 | 17 | |
| 11 | 2017 | 5 |
About Ian E. Anglin
Ian E. Anglin is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Cancer Research, having authored 11 papers that have together received 464 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), NF-κB Signaling Pathways (2 papers), Ubiquitin and proteasome pathways (2 papers), Prostate Cancer Treatment and Research (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Parasites and Host Interactions (1 paper), Toxoplasma gondii Research Studies (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Urology (35 citations), Cancer Research (76 citations), Cell Biology (87 citations), Molecular Biology (222 citations) and Oncology (79 citations). Ian E. Anglin has collaborated with scholars based in United States, Thailand and Australia. Frequent co-authors include Natasha Kyprianou, James Partin, Antonino Passaniti, Deborah T. Glassman, Michele Vítolo, Toni Antalis, Kurtis E. Bachman, Ronald B. Gartenhaus, William M. Mahoney and Sarah Netzel–Arnett. Their work appears in journals such as International Journal of Cancer, Experimental Lung Research, Prostate Cancer and Prostatic Diseases, Cancer Biology & Therapy and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.